Experienced in Menopause

Dr. Richard A. Preston

Nephrology
1611 Nw 12th Ave, Box 016960 M851, 
Miami, FL 
Accepting New Patients
Experienced in Menopause
1611 Nw 12th Ave, Box 016960 M851, 
Miami, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Richard Preston is a Nephrologist in Miami, Florida. Dr. Preston is rated as an Experienced provider by MediFind in the treatment of Menopause. His top areas of expertise are Chronic Kidney Disease and Menopause. Dr. Preston is currently accepting new patients.

His clinical research consists of co-authoring 53 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Menopause.

Specialties
Nephrology
Licenses
Internal Medicine in FL
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Florida Blue
  • EPO
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Oscar
  • EPO
  • HMO
  • PPO

Locations

1611 Nw 12th Ave, Box 016960 M851, Miami, FL 33136

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase 1, 2-Part, Open-Label, Single-Dose, Parallel Group Study to Determine the Effect of Hepatic Impairment on the Safety, Tolerability, and Pharmacokinetics of ACH-0144471 in Adult Subjects
A Phase 1, 2-Part, Open-Label, Single-Dose, Parallel Group Study to Determine the Effect of Hepatic Impairment on the Safety, Tolerability, and Pharmacokinetics of ACH-0144471 in Adult Subjects
Enrollment Status: Completed
Publish Date: August 20, 2021
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics of Setmelanotide in Subjects With Varying Degrees of Renal Impairment
A Phase 1, Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics of Setmelanotide in Subjects With Varying Degrees of Renal Impairment
Enrollment Status: Completed
Publish Date: June 30, 2021
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Open-label, Single-dose, Parallel-group Study to Evaluate the Effects of Renal Impairment on the Pharmacokinetics of ELX-02
A Phase 1, Open-label, Single-dose, Parallel-group Study to Evaluate the Effects of Renal Impairment on the Pharmacokinetics of ELX-02
Enrollment Status: Completed
Publish Date: April 13, 2021
Intervention Type: Drug
Study Phase: Phase 1
A Phase I, Open Label, Multi-center, Parallel Cohort, Single Dose Study to Evaluate the Pharmacokinetics of LEE011 in Healthy Subjects With Normal Hepatic Function and Subjects With Impaired Hepatic Function.
A Phase I, Open Label, Multi-center, Parallel Cohort, Single Dose Study to Evaluate the Pharmacokinetics of LEE011 in Healthy Subjects With Normal Hepatic Function and Subjects With Impaired Hepatic Function.
Enrollment Status: Completed
Publish Date: December 19, 2020
Intervention Type: Drug
Study Phase: Phase 1
An Open Label, Single-dose, Multi-center, Parallel-group, Two-staged Study to Evaluate Pharmacokinetics of Oral cMET Inhibitor INC280 in Non-Cancer Subjects With Impaired Hepatic Function and Non-Cancer Subjects With Normal Hepatic Function
An Open Label, Single-dose, Multi-center, Parallel-group, Two-staged Study to Evaluate Pharmacokinetics of Oral cMET Inhibitor INC280 in Non-Cancer Subjects With Impaired Hepatic Function and Non-Cancer Subjects With Normal Hepatic Function
Enrollment Status: Completed
Publish Date: December 10, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Open-label, Single-dose, Multicenter, Parallel Group Study to Assess the Pharmacokinetics and Safety of Alpelisib (BYL719) in Subjects With Hepatic Impairment Compared to Matched Healthy Control Subjects.
A Phase 1, Open-label, Single-dose, Multicenter, Parallel Group Study to Assess the Pharmacokinetics and Safety of Alpelisib (BYL719) in Subjects With Hepatic Impairment Compared to Matched Healthy Control Subjects.
Enrollment Status: Completed
Publish Date: December 09, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Phase I, Open-label, Multi-center, Single-dose Study to Evaluate the Pharmacokinetics of ABL001 in Healthy Subjects With Normal Hepatic Function and Subjects With Impaired Hepatic Function
A Phase I, Open-label, Multi-center, Single-dose Study to Evaluate the Pharmacokinetics of ABL001 in Healthy Subjects With Normal Hepatic Function and Subjects With Impaired Hepatic Function
Enrollment Status: Completed
Publish Date: December 08, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Open-label, Single-dose Study to Investigate the Pharmacokinetics of Intravenous WCK 5222 (FEP-ZID) in Patients With Renal Impairment
A Phase 1, Open-label, Single-dose Study to Investigate the Pharmacokinetics of Intravenous WCK 5222 (FEP-ZID) in Patients With Renal Impairment
Enrollment Status: Completed
Publish Date: August 02, 2018
Intervention Type: Drug
Study Phase: Phase 1
View 7 Less Clinical Trials

53 Total Publications

Pharmacokinetics, safety, and tolerability of fedratinib in adults with moderate and severe hepatic impairment: results from the phase 1 FEDR-CP-001 trial.
Pharmacokinetics, safety, and tolerability of fedratinib in adults with moderate and severe hepatic impairment: results from the phase 1 FEDR-CP-001 trial.
Journal: Cancer chemotherapy and pharmacology
Published: January 02, 2025
Similar Doctors
Experienced in Menopause
Dr. Mario A. Almeida-Suarez
Nephrology
Experienced in Menopause
Dr. Mario A. Almeida-Suarez
Nephrology

Mario A Almeida MD PA

7000 Sw 62nd Ave, Suite 605, 
South Miami, FL 
 (7.8 miles away)
305-669-3360
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Mario Almeida-Suarez is a Nephrologist in South Miami, Florida. Dr. Almeida-Suarez is rated as an Advanced provider by MediFind in the treatment of Menopause. His top areas of expertise are Necrosis, Milk-Alkali Syndrome, Hypercalcemia, Hemorrhoidectomy, and Ureteroscopy. Dr. Almeida-Suarez is currently accepting new patients.

Experienced in Menopause
Dr. Maria R. Cortti-Ferrari
Nephrology
Experienced in Menopause
Dr. Maria R. Cortti-Ferrari
Nephrology

Associatesmd Medical Group Inc

350 N W 84th Ave, Suite 200, 
Plantation, FL 
 (23.3 miles away)
954-577-2294
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Maria Cortti-Ferrari is a Nephrologist in Plantation, Florida. Dr. Cortti-Ferrari is rated as an Experienced provider by MediFind in the treatment of Menopause. Her top areas of expertise are Vitamin D Deficiency, Protein Deficiency, Nephrosclerosis, and Renovascular Hypertension. Dr. Cortti-Ferrari is currently accepting new patients.

Experienced in Menopause
Dr. Alan L. Rose
Nephrology
Experienced in Menopause
Dr. Alan L. Rose
Nephrology
4401 Hollywood Blvd, 
Hollywood, FL 
 (15.2 miles away)
954-962-2211
Languages Spoken:
English
See accepted insurances

Alan Rose is a Nephrologist in Hollywood, Florida. Dr. Rose is rated as an Experienced provider by MediFind in the treatment of Menopause. His top area of expertise is Menopause.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Preston's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile